| Pharmaceutical active ingredients: |
| Alfuzosin Hydrochloride |
| Available forms, composition and doses of Alfuzosine L.P.: |
| Tablets, Sustained Release; Oral; Alfuzosin Hydrochloride 10 mg |
| Alfuzosine L.P. medical category: |
| Human:Drugs for bladder and prostate disordersSelective alfa-1-adrenergic blocking agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G04CA01 - Alfuzosin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| EG Labo |